What is SEAMLESS?
The SEAMLESS Study seeks to investigate innovative ways to deliver psychotherapy interventions using technology. The study aims to assess the effectiveness of a 4-week mobile app-based mindfulness intervention for people living with cancer after they have completed their treatments.
The SEAMLESS study is a result of a Canada-wide collaboration between researchers at the University of Calgary Cumming School of Medicine, Tom Baker Cancer Center, the Canadian Cancer Trial Group and technology developers, Mobio Interactive Inc.
Eligibility
01.
Canadian resident
02.
Cancer diagnosis
03.
Completed cancer treatment
04.
Access to smartphone/tablet
What will you be doing?
-
Listening to audio sessions in the AM mindfulness app for 20-30 minutes daily for 4 weeks
-
Filling out online surveys before and after the app intervention and at various follow-up time points
